Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chemistry & Biodiversity|February 27, 2025
Integrated Computational and Experimental Insights Into MEK1/2 Inhibitors: Structural Validation, Docking, ADMET, Molecular Dynamics, and Anticancer EvaluationRohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli
Chemmedchem|February 25, 2026
Therapeutic Approaches to Treat SARS-CoV-2Lekhnath Sharma, Neelesh Maheshwari, Nupur Maheshwari, et al.
European Journal of Medicinal Chemistry|November 17, 2023
Synthetic product-based approach toward potential antileishmanial drug developmentRohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry|July 8, 2023
The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasisRohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
Molecular Diversity|July 3, 2025
Design strategies, structural insights, and biological potential of amyloid-beta inhibitors in Alzheimer's diseaseMridul Guleria, Arprita Malhan, Ghanshyam Teli, et al.
Journal of Biomolecular Structure & Dynamics|May 5, 2023
Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinaseGhanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Journal of Biomolecular Structure & Dynamics|August 29, 2023
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Bioorganic Chemistry|August 21, 2024
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure-activity relationshipRohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Chemistry & Biodiversity|April 19, 2025
Design, Synthesis, and Molecular Profiling of Pyrimidine-Furan Derivatives Targeting EGFRWT, EGFRT790M, and EGFRL858R/T790M/C797S in NSCLC: In Vitro and In Silico EvaluationRohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Chemistry & Biodiversity|August 11, 2023
Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity RelationshipGhanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Pageof 2